Invention Grant
US08562968B2 Use of stem cells and CD6 depleted stem cells for the induction of tolerance to allogenic transplants and/or for the treatment of leukemia
失效
使用干细胞和CD6消耗干细胞诱导同种异体移植和/或治疗白血病的耐受性
- Patent Title: Use of stem cells and CD6 depleted stem cells for the induction of tolerance to allogenic transplants and/or for the treatment of leukemia
- Patent Title (中): 使用干细胞和CD6消耗干细胞诱导同种异体移植和/或治疗白血病的耐受性
-
Application No.: US10410852Application Date: 2003-04-10
-
Publication No.: US08562968B2Publication Date: 2013-10-22
- Inventor: Wolfgang Günther , Hans Jochen Kolb
- Applicant: Wolfgang Günther , Hans Jochen Kolb
- Applicant Address: DE Oberschleiβheim
- Assignee: GSF-Forshungszentrum für Umwelt und Gesundheit, GmbH
- Current Assignee: GSF-Forshungszentrum für Umwelt und Gesundheit, GmbH
- Current Assignee Address: DE Oberschleiβheim
- Agency: Jenkins, Wilson, Taylor & Hunt, P.A.
- Priority: DE10050334 20001011
- Main IPC: A01N63/00
- IPC: A01N63/00 ; C12N5/00 ; C12N5/08 ; A61F13/00
Abstract:
The present invention relates to the use of a composition containing stem cells as well as CD6 depleted stem cells for the induction of a tolerance to allogenic transplants and/or for the treatment of blood, immune, and cancer diseases for time-staggered application wherein first the stem cells are applied followed by application of the CD6 depleted stem cells. Furthermore, the present invention relates to a compound preparation containing stem cells and CD6 depleted stem cells.
Public/Granted literature
Information query
